The study indicated that IGF2BP3–RASGRF1‐mediated mTORC1 activation played a major role in the CEL‐mediated inhibition of cell proliferation and inflammatory cytokine release in RA‐FLS. This evidence concerns the gene IGF2BP3 and rheumatoid arthritis.